be_ixf;ym_202604 d_12; ct_50

Latest Insights on RTN

Nikola’s new deal with GM raises serious concerns about the company’s hydrogen fuel cell technology (again). Nikola’s Heart Attack; Picking up the Slack; Moderna’s Back November 30, 2020 by Joseph Hargett Great Stuff But I Said No Take-Backsies! You ever have a deal go bad on you? Like, I don’t know … you finally get an order confirmation for a PlayStation 5 — something you dreamt about buying since it launched — and all of a sudden, that order gets canceled? No warning. No indication that anything’s wrong. […]
Bull market? Bear market? Brian Christopher doesn’t care. His Flow Matrix Alert research can help you make money in any trading environment. The Matrix Has You: Interviewing Trading Expert Brian Christopher November 20, 2020 by Joseph Hargett Great Stuff Bull market? Bear market? Brian Christopher doesn’t care. His Flow Matrix Alert research can help you make money in any trading environment.
We asked you for DoorDash opinions, and boy, we got ‘em! Get the latest on the DoorDash IPO — and if should buy in when DASH goes public. DoorDash Rehash; I’m With the BAND; Uber’s Robo-Taxi No More November 19, 2020 by Joseph Hargett Great Stuff Knocking on Heaven’s Door(Dash) Great Ones … welcome to Reader Feedback day! If you happen to be new ‘round these parts, today’s the day that Great Stuff answers your questions, researches your investment ideas and indulges in your rants … whatever the topic may be. Seriously. Last week, we covered everything from artificial intelligence to […]
What You Can Learn From Pfizer’s CEO November 18, 2020 by Michael Carr Trading Strategies, Winning Investor Daily Top company officers usually have a plan for selling their shares.
The effectiveness of the COVID-19 vaccine is remarkable. But what’s even more remarkable is that a relatively small firm played such a large role in developing it. COVID-19 Vaccine Firm Soars 650% — Huge Opportunities Ahead November 14, 2020 by Jay Goldberg Investment Opportunities, Winning Investor Daily The effectiveness of the COVID-19 vaccine is remarkable. But what’s even more remarkable is that a relatively small firm played such a large role in developing it.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

Share This